Zurich Cantonal Bank’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,933
Closed -$16K 2738
2021
Q4
$16K Sell
1,933
-201
-9% -$1.98K ﹤0.01% 2873
2021
Q3
$27K Buy
2,134
+3
+0.1% +$42 ﹤0.01% 2755
2021
Q2
$33K Buy
2,131
+196
+10% +$3.29K ﹤0.01% 2531
2021
Q1
$39K Buy
+1,935
New +$47.8K ﹤0.01% 2458

Other funds holding CLLS

Zurich Cantonal Bank's CLLS Position: Q1 2022 in Review

Zurich Cantonal Bank sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 1,933 shares — an estimated $16K sold.

Zurich Cantonal Bank first reported a position in CLLS in Q1 2021 and held it in 4 quarters. The position peaked at $39K in Q1 2021. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.

  • Zurich Cantonal Bank reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,933 Cellectis shares in Q1 2022, an estimated $16K.
  • Zurich Cantonal Bank first reported a position in Cellectis in Q1 2021 and held it in 4 quarters.
  • Zurich Cantonal Bank's Cellectis position peaked at $39K in Q1 2021.
  • 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.